Do not trade this blog as 4 billion years of evolution is against me and possibly even God laughs at it, He has a great sense of humor! Do you remember these slides from CTAD 2017? I decided to plot all patients in High Concentration Cohort from CTAD 2017 for the first 57 weeks. From … Continue reading $AVXL Blarcaminase Improves APOE e4 gene Carriers in Alzheimer’s
Month: December 2019
CTAD 2019 and Balrcamesine Again. $AVXL
Do not trade on this post as 4 billion years of evolution is against me and God might not agree with me either. LOL It Pays off Being Suspicious. Only the Paranoid Survive... I suspected that the curve for deterioration of the general progress of Alzheimer's disease might likely contain a region of acceleration. … Continue reading CTAD 2019 and Balrcamesine Again. $AVXL
First Impressions from CTAD 2019 Presentation. $AVXL Blarcamesine
Don't trade this post as 4 billion years of evolution and possibly God is against my judgment The beginning of the presentation dwells on advancement in clinical studies beyond the slow process of adding sources of information to process which might have not changed for decades towards a revolution. It seems that now … Continue reading First Impressions from CTAD 2019 Presentation. $AVXL Blarcamesine
There is Nothing like Blarcamesine in the Alzheimer’s Drug Search $AVXL
Do not trade on this post since 4 billion years of evolution and God himself might be against my conclusions! Seekingalpha.com had on 12 04 2019 this press release. The only problem with this press release is that it is warmed up info already given by $AVXL when it for the first time revealed … Continue reading There is Nothing like Blarcamesine in the Alzheimer’s Drug Search $AVXL